News	Events
Publications	Companies
Clinical Trials

Tag Archives: AtuPLEX

• Silence Therapeutics signs collaboration with Mirna Therapeutics to evaluate delivery of novel microRNA therapeutics

  1 Reply
  

  October 24, 2011

  --Collaboration to investigate potential application of Silence’s novel AtuPLEX™ and DBTC delivery technologies in the development of novel microRNA therapeutics targeting cancer -- London, UK October XX, 2011 –Silence Therapeutics plc (AIM: SLN) (“Silence”), a leading RNA interference (RNAi) therapeutics company, today announced that it has entered into an agreement... Contine Reading & Discuss→

• Appointment of Chief Executive Officer

  0 Replies
  

  September 30, 2011

  London, September 20, 2011 – Silence Therapeutics plc (AIM: SLN) (“Silence”, the “Group” or the “Company”), a leading global RNA interference (RNAi) therapeutics company, today announces the appointment of Thomas Christély as Chief Executive Officer with immediate effect. He will be based at Silence’s facility in Berlin. Thomas Christély (aged... Contine Reading & Discuss→